A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

NCT00559091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelocytic Leukemia

Interventions

DRUG: ribavirin

Sponsor

Jewish General Hospital

Collaborators

[object Object]